ANKH | ANKH inorganic pyrophosphate transport regulator | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
CLCN4 | Chloride channel, voltage-sensitive 4 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CLCN7 | Chloride channel, voltage-sensitive 7 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
CTNS | Cystinosin, lysosomal cystine transporter | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
EI24 | Etoposide induced 2.4 | Cancer-related genes Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
FLVCR1 | Feline leukemia virus subgroup C cellular receptor 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
FLVCR2 | Feline leukemia virus subgroup C cellular receptor family, member 2 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Mixed |
HIATL1 | Hippocampus abundant transcript-like 1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
HMGCR | 3-hydroxy-3-methylglutaryl-CoA reductase | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
LAPTM4B | Lysosomal protein transmembrane 4 beta | Predicted membrane proteins Transporters
| | | | | Expressed in all |
LAPTM5 | Lysosomal protein transmembrane 5 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
LETM1 | Leucine zipper-EF-hand containing transmembrane protein 1 | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
MFSD2A | Major facilitator superfamily domain containing 2A | Predicted membrane proteins Transporters
| | | | | Mixed |
MFSD6L | Major facilitator superfamily domain containing 6-like | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
MFSD8 | Major facilitator superfamily domain containing 8 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
MLC1 | Megalencephalic leukoencephalopathy with subcortical cysts 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
MPC1 | Mitochondrial pyruvate carrier 1 | Disease related genes Mitochondrial proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
MPC2 | Mitochondrial pyruvate carrier 2 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
MTCH1 | Mitochondrial carrier 1 | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
MTCH2 | Mitochondrial carrier 2 | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
NIPA1 | Non imprinted in Prader-Willi/Angelman syndrome 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
NIPA2 | Non imprinted in Prader-Willi/Angelman syndrome 2 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
NIPAL3 | NIPA-like domain containing 3 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
NIPAL4 | NIPA-like domain containing 4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
NPC1 | Niemann-Pick disease, type C1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
NPC2 | Niemann-Pick disease, type C2 | Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
OCA2 | Oculocutaneous albinism II | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
OXA1L | Oxidase (cytochrome c) assembly 1-like | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
PQLC2 | PQ loop repeat containing 2 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
RFT1 | RFT1 homolog (S. cerevisiae) | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
SFXN4 | Sideroflexin 4 | Disease related genes Mitochondrial proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC10A1 | Solute carrier family 10 (sodium/bile acid cotransporter), member 1 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC10A2 | Solute carrier family 10 (sodium/bile acid cotransporter), member 2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC10A3 | Solute carrier family 10, member 3 | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
SLC10A4 | Solute carrier family 10, member 4 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC10A5 | Solute carrier family 10, member 5 | Predicted membrane proteins Transporters
| | | | | Mixed |
SLC10A7 | Solute carrier family 10, member 7 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Mixed |
SLC11A1 | Solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC11A2 | Solute carrier family 11 (proton-coupled divalent metal ion transporter), member 2 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC12A1 | Solute carrier family 12 (sodium/potassium/chloride transporter), member 1 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC12A2 | Solute carrier family 12 (sodium/potassium/chloride transporter), member 2 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC12A3 | Solute carrier family 12 (sodium/chloride transporter), member 3 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC12A4 | Solute carrier family 12 (potassium/chloride transporter), member 4 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC12A5 | Solute carrier family 12 (potassium/chloride transporter), member 5 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC12A6 | Solute carrier family 12 (potassium/chloride transporter), member 6 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC12A7 | Solute carrier family 12 (potassium/chloride transporter), member 7 | Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC12A8 | Solute carrier family 12, member 8 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC13A1 | Solute carrier family 13 (sodium/sulfate symporter), member 1 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC13A2 | Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC13A3 | Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |